- Home
- RLAY vs LAZ Comparison
RLAY vs LAZ Comparison
Compare RLAY & LAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RLAY | LAZ |
|---|---|---|
| Founded | 2015 | 1848 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.7B |
| IPO Year | 2020 | 2004 |
Fundamental Metrics
Financial Performance| Metric | RLAY | LAZ |
|---|---|---|
| Price | $20.01 | $41.41 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 8 |
| Target Price | $19.50 | ★ $52.75 |
| AVG Volume (30 Days) | ★ 4.2M | 2.9M |
| Earning Date | 05-05-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 4.21% |
| EPS Growth | ★ 31.78 | N/A |
| EPS | N/A | ★ 0.91 |
| Revenue | $15,355,000.00 | ★ $3,186,466,000.00 |
| Revenue This Year | N/A | $13.36 |
| Revenue Next Year | $324.03 | $13.72 |
| P/E Ratio | ★ N/A | $45.82 |
| Revenue Growth | ★ 53.44 | 1.48 |
| 52 Week Low | $3.03 | $38.67 |
| 52 Week High | $20.79 | $58.75 |
Technical Indicators
Market Signals| Indicator | RLAY | LAZ |
|---|---|---|
| Relative Strength Index (RSI) | 67.09 | 44.66 |
| Support Level | $12.10 | $39.33 |
| Resistance Level | N/A | $51.35 |
| Average True Range (ATR) | 1.31 | 1.90 |
| MACD | 0.17 | 0.12 |
| Stochastic Oscillator | 85.38 | 44.08 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
About LAZ Lazard Inc.
Lazard Inc is a financial advisory and asset management firm with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. Geographically, the company earns key revenue in the Americas, EMEA then Asia-Pacific.